Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Involvement of plasma miRNAs, muscle miRNAs and mitochondrial miRNAs in the pathophysiology of frailty.

Rusanova I, Fernández-Martínez J, Fernández-Ortiz M, Aranda-Martínez P, Escames G, García-García FJ, Mañas L, Acuña-Castroviejo D.

Exp Gerontol. 2019 Jun 12;124:110637. doi: 10.1016/j.exger.2019.110637. [Epub ahead of print] Review.

PMID:
31199979
2.

MitomiRs in human inflamm-aging: a hypothesis involving miR-181a, miR-34a and miR-146a.

Rippo MR, Olivieri F, Monsurrò V, Prattichizzo F, Albertini MC, Procopio AD.

Exp Gerontol. 2014 Aug;56:154-63. doi: 10.1016/j.exger.2014.03.002. Epub 2014 Mar 7. Review.

PMID:
24607549
3.

Analysis of Plasma MicroRNAs as Predictors and Biomarkers of Aging and Frailty in Humans.

Rusanova I, Diaz-Casado ME, Fernández-Ortiz M, Aranda-Martínez P, Guerra-Librero A, García-García FJ, Escames G, Mañas L, Acuña-Castroviejo D.

Oxid Med Cell Longev. 2018 Jul 18;2018:7671850. doi: 10.1155/2018/7671850. eCollection 2018.

4.

The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.

Duarte FV, Palmeira CM, Rolo AP.

Adv Exp Med Biol. 2015;888:123-54. doi: 10.1007/978-3-319-22671-2_8.

PMID:
26663182
5.

Identifying Exosome-Derived MicroRNAs as Candidate Biomarkers of Frailty.

Ipson BR, Fletcher MB, Espinoza SE, Fisher AL.

J Frailty Aging. 2018;7(2):100-103. doi: 10.14283/jfa.2017.45.

6.

Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Bandiera S, Pernot S, El Saghire H, Durand SC, Thumann C, Crouchet E, Ye T, Fofana I, Oudot MA, Barths J, Schuster C, Pessaux P, Heim MH, Baumert TF, Zeisel MB.

J Virol. 2016 Jun 24;90(14):6387-6400. doi: 10.1128/JVI.00619-16. Print 2016 Jul 15.

7.

Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology.

Nguyen LS, Lepleux M, Makhlouf M, Martin C, Fregeac J, Siquier-Pernet K, Philippe A, Feron F, Gepner B, Rougeulle C, Humeau Y, Colleaux L.

Mol Autism. 2016 Jan 8;7:1. doi: 10.1186/s13229-015-0064-6. eCollection 2016.

8.

miRNA and cancer; computational and experimental approaches.

Tutar Y.

Curr Pharm Biotechnol. 2014;15(5):429.

PMID:
25189575
9.

Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?

Giuliani A, Prattichizzo F, Micolucci L, Ceriello A, Procopio AD, Rippo MR.

Mediators Inflamm. 2017;2017:2309034. doi: 10.1155/2017/2309034. Epub 2017 Dec 27. Review.

10.

MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.

Schaefer JS, Attumi T, Opekun AR, Abraham B, Hou J, Shelby H, Graham DY, Streckfus C, Klein JR.

BMC Immunol. 2015 Feb 10;16:5. doi: 10.1186/s12865-015-0069-0.

11.

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.

Dalmasso B, Hatse S, Brouwers B, Laenen A, Berben L, Kenis C, Smeets A, Neven P, Schöffski P, Wildiers H.

BMC Cancer. 2018 Oct 22;18(1):1014. doi: 10.1186/s12885-018-4920-6.

12.

Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.

Chang TY, Tsai WC, Huang TS, Su SH, Chang CY, Ma HY, Wu CH, Yang CY, Lin CH, Huang PH, Cheng CC, Cheng SM, Wang HW.

PLoS One. 2017 Jul 20;12(7):e0181562. doi: 10.1371/journal.pone.0181562. eCollection 2017.

13.

Rapid upregulation and clearance of distinct circulating microRNAs after prolonged aerobic exercise.

Baggish AL, Park J, Min PK, Isaacs S, Parker BA, Thompson PD, Troyanos C, D'Hemecourt P, Dyer S, Thiel M, Hale A, Chan SY.

J Appl Physiol (1985). 2014 Mar 1;116(5):522-31. doi: 10.1152/japplphysiol.01141.2013. Epub 2014 Jan 16.

14.

Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.

Navickas R, Gal D, Laucevičius A, Taparauskaitė A, Zdanytė M, Holvoet P.

Cardiovasc Res. 2016 Sep;111(4):322-37. doi: 10.1093/cvr/cvw174. Epub 2016 Jun 29. Review.

15.

Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Kumar S, Reddy PH.

Biochim Biophys Acta. 2016 Sep;1862(9):1617-27. doi: 10.1016/j.bbadis.2016.06.001. Epub 2016 Jun 2. Review.

16.
17.

Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis.

Murata K, Yoshitomi H, Tanida S, Ishikawa M, Nishitani K, Ito H, Nakamura T.

Arthritis Res Ther. 2010;12(3):R86. doi: 10.1186/ar3013. Epub 2010 May 14.

18.

MicroRNAs as potential signatures of environmental exposure or effect: a systematic review.

Vrijens K, Bollati V, Nawrot TS.

Environ Health Perspect. 2015 May;123(5):399-411. doi: 10.1289/ehp.1408459. Epub 2015 Jan 16. Review.

19.
20.

MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.

Assmann TS, Recamonde-Mendoza M, De Souza BM, Crispim D.

Endocr Connect. 2017 Nov;6(8):773-790. doi: 10.1530/EC-17-0248. Epub 2017 Oct 6.

Supplemental Content

Support Center